Manmeet S. Soni

2019 - REATA PHARMACEUTICALS

In 2019, Manmeet S. Soni earned a total compensation of $12.6M as Chief Financial Officer and Executive Vice President at REATA PHARMACEUTICALS.

Compensation breakdown

Bonus$408,873
Option Awards$11,603,086
Salary$530,000
Other$70,243
Total$12,612,202

Soni received $11.6M in option awards, accounting for 92% of the total pay in 2019.

Soni also received $408.9K in bonus, $530K in salary and $70.2K in other compensation.

Rankings

In 2019, Manmeet S. Soni's compensation ranked 480th out of 13,971 executives tracked by ExecPay. In other words, Soni earned more than 96.6% of executives.

ClassificationRankingPercentile
All
480
out of 13,971
97th
Division
Manufacturing
178
out of 5,695
97th
Major group
Chemicals And Allied Products
46
out of 2,194
98th
Industry group
Drugs
38
out of 1,880
98th
Industry
Pharmaceutical Preparations
31
out of 1,392
98th
Source: SEC filing on April 29, 2020.

Soni's colleagues

We found five more compensation records of executives who worked with Manmeet S. Soni at REATA PHARMACEUTICALS in 2019.

2019

J Huff

REATA PHARMACEUTICALS

Chief Executive Officer

2019

Colin Meyer

REATA PHARMACEUTICALS

Chief Medical Officer

2019

Jason Wilson

REATA PHARMACEUTICALS

Executive Vice President, Operations

2019

Michael Wortley

REATA PHARMACEUTICALS

Chief Legal Officer

2019

Dawn Bir

REATA PHARMACEUTICALS

Chief Commercial Officer and Executive Vice President

News

In-depth

You may also like